Core Insights - The prevalence of fatty liver disease among adults in China has reached 40%, driven by unhealthy lifestyles such as high-fat diets and sedentary behavior [2][6] - LAIFE has introduced a product, LIVEREJUVER, claiming to reverse fatty liver in 90 days, backed by a money-back guarantee, which has garnered significant consumer interest [2][6] - The product's development leverages an AI platform, RevOrgan, which accelerates the discovery of effective components for liver health management [5][9] Industry Overview - The fatty liver disease market is expanding due to the increasing incidence of the condition, particularly among younger populations [2][6] - Traditional liver health products often focus on symptom relief rather than measurable intervention effects, creating a gap in the market for more effective solutions [2][6] Product Innovation - LAIFE's LR13 formula employs a dual-channel mechanism to address fatty liver: a probiotic matrix that intercepts dietary fats and an amino acid matrix that enhances liver detoxification [6][9] - Clinical trials have shown that the LR13 formula can reduce triglyceride levels by an average of 28.7% within 90 days, demonstrating quantifiable health benefits [5][9] Consumer Trends - There is a shift in consumer expectations from vague health claims to scientifically validated results, prompting companies to adopt data-driven approaches in product development [9] - LAIFE's commitment to a "90-day no-questions-asked refund" policy reflects a growing trend towards transparency and accountability in health product marketing [9]